Chapter 2 - University of British Columbia

16. Walsh CS, Ogawa S, Scoles DR, Miller CW, Kawamata N, Narod SA, Koeffler HP,
Karlan BY: Genome-wide loss of heterozygosity and uniparental disomy in
BRCA1/2-associated ovarian carcinomas. Clin Cancer Res 2008, 14(23):7645-7651.
17. Kralovics R, Guan Y, Prchal JT: Acquired uniparental disomy of chromosome 9p is
a frequent stem cell defect in polycythemia vera. Exp Hematol 2002, 30(3):229-236.
18. Grand FH, Hidalgo-Curtis CE, Ernst T, Zoi K, Zoi C, McGuire C, Kreil S, Jones A, Score
J, Metzgeroth G et al: Frequent CBL mutations associated with 11q acquired
uniparental disomy in myeloproliferative neoplasms. Blood 2009, 113(24):6182-
6192.
19. Fitzgibbon J, Smith LL, Raghavan M, Smith ML, Debernardi S, Skoulakis S, Lillington D,
Lister TA, Young BD: Association between acquired uniparental disomy and
homozygous gene mutation in acute myeloid leukemias. Cancer Res 2005,
65(20):9152-9154.
20. Soh J, Okumura N, Lockwood WW, Yamamoto H, Shigematsu H, Zhang W, Chari R,
Shames DS, Tang X, MacAulay C et al: Oncogene mutations, copy number gains
and mutant allele specific imbalance (MASI) frequently occur together in tumor
cells. PLoS One 2009, 4(10):e7464.
21. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP:
Exploration, normalization, and summaries of high density oligonucleotide array
probe level data. Biostatistics 2003, 4(2):249-264.
22. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L,
Ge Y, Gentry J et al: Bioconductor: open software development for computational
biology and bioinformatics. Genome Biol 2004, 5(10):R80.
23. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, Sougnez C,
Greulich H, Muzny DM, Morgan MB et al: Somatic mutations affect key pathways in
lung adenocarcinoma. Nature 2008, 455(7216):1069-1075.
24. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton
MR: A census of human cancer genes. Nat Rev Cancer 2004, 4(3):177-183.
25. Lockwood WW, Chari R, Coe BP, Girard L, Macaulay C, Lam S, Gazdar AF, Minna JD,
Lam WL: DNA amplification is a ubiquitous mechanism of oncogene activation in
lung and other cancers. Oncogene 2008, 27(33):4615-4624.
26. Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R, Lin WM, Province MA, Kraja
A, Johnson LA et al: Characterizing the cancer genome in lung adenocarcinoma.
Nature 2007, 450(7171):893-898.
27. Chitale D, Gong Y, Taylor BS, Broderick S, Brennan C, Somwar R, Golas B, Wang L,
Motoi N, Szoke J et al: An integrated genomic analysis of lung cancer reveals loss
of DUSP4 in EGFR-mutant tumors. Oncogene 2009, 28(31):2773-2783.
28. Kendall J, Liu Q, Bakleh A, Krasnitz A, Nguyen KC, Lakshmi B, Gerald WL, Powers S,
Mu D: Oncogenic cooperation and coamplification of developmental transcription
factor genes in lung cancer. Proc Natl Acad Sci U S A 2007, 104(42):16663-16668.
29. Garnis C, Lockwood WW, Vucic E, Ge Y, Girard L, Minna JD, Gazdar AF, Lam S,
MacAulay C, Lam WL: High resolution analysis of non-small cell lung cancer cell
lines by whole genome tiling path array CGH. Int J Cancer 2006, 118(6):1556-1564.
30. Borczuk AC, Gorenstein L, Walter KL, Assaad AA, Wang L, Powell CA: Non-small-cell
lung cancer molecular signatures recapitulate lung developmental pathways. Am J
Pathol 2003, 163(5):1949-1960.
31. Cooper CS, Nicholson AG, Foster C, Dodson A, Edwards S, Fletcher A, Roe T, Clark J,
Joshi A, Norman A et al: Nuclear overexpression of the E2F3 transcription factor in
human lung cancer. Lung Cancer 2006, 54(2):155-162.
32. Goransson H, Edlund K, Rydaker M, Rasmussen M, Winquist J, Ekman S, Bergqvist M,
Thomas A, Lambe M, Rosenquist R et al: Quantification of normal cell fraction and
copy number neutral LOH in clinical lung cancer samples using SNP array data.
PLoS One 2009, 4(6):e6057.
109